10 October 2024
10 October 2024 TREATT PLC (“Treatt” or “the Group”) Trading update for the year ended 30 September 2024 Strong H2 momentum with full year…
Statement: Zantac (ranitidine) litigation – settlement agreements reached · GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac product liability cases for…
9 October 2024
9 October 2024 World-class lithium business to strengthen Rio Tinto’s position as global leader inenergy transition commodities Counter-cyclical expansion into a high-growth market, aligned…
8 October 2024
8 October 2024 Harworth Group plc (“Harworth” or “the Group”) Harworth acquires 285,000 sq. ft. newly developed Grade A urban logistics scheme in South…
7 October 2024
The following is an update to the third quarter 2024 outlook and gives an overview of our current expectations for the third quarter. Outlooks…
Rio Tinto today confirmed that it has made an approach to Arcadium Lithium regarding a potential acquisition of Arcadium Lithium by Rio Tinto. The approach…
7 October 2024 AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy AstraZeneca has entered into an exclusive license agreement…
7 October 2024 Assura plc Trading update for the first half ended 30 September 2024 Assura plc (“Assura”), the diversified healthcare REIT, today announces…